Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Teva
Moodys
Healthtrust
US Department of Justice
Deloitte
AstraZeneca
Queensland Health
Argus Health

Generated: October 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021047

« Back to Dashboard

NDA 021047 describes REPRONEX, which is a drug marketed by Ferring and is included in one NDA. Additional details are available on the REPRONEX profile page.

The generic ingredient in REPRONEX is menotropins (fsh;lh). There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the menotropins (fsh;lh) profile page.
Summary for 021047
Tradename:REPRONEX
Applicant:Ferring
Ingredient:menotropins (fsh;lh)
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUSStrength75 IU/VIAL;75 IU/VIAL
Approval Date:Aug 27, 1999TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength150 IU/VIAL;150 IU/VIAL
Approval Date:Aug 27, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
UBS
Argus Health
Accenture
Mallinckrodt
Colorcon
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.